Literature DB >> 32718409

Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy.

J L Kadota1, A Katamba2, A Musinguzi3, F Welishe3, J Nabunje3, J L Ssemata3, C A Berger1, M R Kamya4, J Namusobya5, F C Semitala6, A Cattamanchi7, D W Dowdy8.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32718409      PMCID： PMC7891860          DOI： 10.5588/ijtld.20.0010

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  12 in total

1.  Activism on rifapentine pricing: removing cost barriers to improve the uptake of tuberculosis research innovations.

Authors:  A DeLuca; M Frick; E Lessem; J Kanouse; D Wegener; L Ruiz Mingote
Journal:  Public Health Action       Date:  2014-12-21

2.  Attitudes and Perceptions Towards Access and Use of the Formal Healthcare Sector in Northern Malawi.

Authors:  Emily Fisher; Rebecca Lazarus; Ramin Asgary
Journal:  J Health Care Poor Underserved       Date:  2017

3.  Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.

Authors:  Robert Belknap; David Holland; Pei-Jean Feng; Joan-Pau Millet; Joan A Caylà; Neil A Martinson; Alicia Wright; Michael P Chen; Ruth N Moro; Nigel A Scott; Bert Arevalo; José M Miró; Margarita E Villarino; Marc Weiner; Andrey S Borisov
Journal:  Ann Intern Med       Date:  2017-11-07       Impact factor: 25.391

4.  Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania.

Authors:  P J Munseri; E A Talbot; L Mtei; C Fordham von Reyn
Journal:  Int J Tuberc Lung Dis       Date:  2008-09       Impact factor: 2.373

5.  Understanding barriers to emergency care in low-income countries: view from the front line.

Authors:  Adam C Levine; David Z Presser; Stephanie Rosborough; Tedros A Ghebreyesus; Mark A Davis
Journal:  Prehosp Disaster Med       Date:  2007 Sep-Oct       Impact factor: 2.040

Review 6.  Patient adherence to tuberculosis treatment: a systematic review of qualitative research.

Authors:  Salla A Munro; Simon A Lewin; Helen J Smith; Mark E Engel; Atle Fretheim; Jimmy Volmink
Journal:  PLoS Med       Date:  2007-07-24       Impact factor: 11.069

7.  Addressing tuberculosis in differentiated care provision for people living with HIV.

Authors:  Ishani Pathmanathan; Eric Pevzner; Joseph Cavanaugh; Lisa Nelson
Journal:  Bull World Health Organ       Date:  2017-01-01       Impact factor: 9.408

8.  Investigating socio-economic inequity in access to and expenditures on routine immunization services in Anambra state.

Authors:  Florence T Sibeudu; Benjamin S C Uzochukwu; Obinna E Onwujekwe
Journal:  BMC Res Notes       Date:  2017-02-01

9.  Barriers to access and utilization of emergency obstetric care at health facilities in sub-Saharan Africa: a systematic review of literature.

Authors:  Ayele Geleto; Catherine Chojenta; Abdulbasit Musa; Deborah Loxton
Journal:  Syst Rev       Date:  2018-11-13

10.  Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa.

Authors:  A P Hardon; D Akurut; C Comoro; C Ekezie; H F Irunde; T Gerrits; J Kglatwane; J Kinsman; R Kwasa; J Maridadi; T M Moroka; S Moyo; A Nakiyemba; S Nsimba; R Ogenyi; T Oyabba; F Temu; R Laing
Journal:  AIDS Care       Date:  2007-05
View more
  2 in total

1.  Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.

Authors:  Fred C Semitala; Jillian L Kadota; Allan Musinguzi; Juliet Nabunje; Fred Welishe; Anne Nakitende; Lydia Akello; Opira Bishop; Devika Patel; Amanda Sammann; Payam Nahid; Robert Belknap; Moses R Kamya; Margaret A Handley; Patrick P J Phillips; Anne Katahoire; Christopher A Berger; Noah Kiwanuka; Achilles Katamba; David W Dowdy; Adithya Cattamanchi
Journal:  PLoS Med       Date:  2021-12-16       Impact factor: 11.613

2.  Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives.

Authors:  Fred C Semitala; Allan Musinguzi; Jackie Ssemata; Fred Welishe; Juliet Nabunje; Jillian L Kadota; Christopher A Berger; Achilles Katamba; Noah Kiwanuka; Moses R Kamya; David Dowdy; Adithya Cattamanchi; Anne R Katahoire
Journal:  Implement Sci Commun       Date:  2021-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.